Number of subjects included in the study
| CTL | CMV-UT | CMV-VAL | |
| N | n=8 | n=18 | n=16 |
| Sex | 6 M/2 F | 10 M/8 F | 9 M/7 F |
| Age | 6 months (2–12 months) | 3 months (1 week to 14 months) | 3 months (21 weeks to 16 months) |
| Time on treatment | – | – | 6 months (2 weeks to 12 months) |
Clinical and epidemiological data of the subjects included in the study.
Values are reported as median (IQR). No significant differences were detected according to age (p=0.165).
CMV, cytomegalovirus; CTL, control; F, females; M, males; UT, untreated; VAL, valganciclovir.